Managers

Arteaus Therapeutics sells royalty interest in Emgality for $260 mln

Arteaus Therapeutics, a biotech development company co-founded by Atlas Venture and OrbiMed, has sold its royalty interest in Eli Lilly and Company's Emgality to Royalty Pharma for $260 million. Morgan Stanley was sole structuring agent on the monetization. Wilmer Cutler Pickering Hale and Dorr LLP served as legal adviser to Arteaus while Jones Day and Maiwald served as legal advisers to Royalty Pharma.

BillionToOne fetches $15 mln Series A

Menlo Park, California-based BillionToOne, a precision diagnostics company, has raised $15 million in Series A funding. Hummingbird Ventures and NeoTribe Ventures led the round with participation from Y Combinator, Civilization Ventures, Fifty Years, 500 Startups Istanbul and HOF Capital.

SpringWorks Therapeutics grabs $125 mln Series B

Stamford, Connecticut-based SpringWorks Therapeutics Inc, a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer, has raised $125 million in Series B financing. Perceptive Advisors led the round.

Women's health tech startup NextGen Jane locks in $9 mln Series A

Women's health tech startup NextGen Jane has secured $9 million in Series A funding. Material Impact led the round with participation from other backers that included Access Industries, Viking Global Investors and Liminal Ventures.

Medical device software company Fifth Eye snags $11.5 mln Series A

Ann Arbor, Michigan-based Fifth Eye, a medical device software company, has secured $11.5 million in Series A funding. Arboretum Ventures and Cultivation Capital led the round.

Karuna Therapeutics nabs $12 mln, raising Series B to $80 mln

Karuna Therapeutics has raised an additional $12 million for its Series B round, bringing the total to $80 million. The new investor is Sofinnova Investments. Karuna focuses on targeting muscarinic cholinergic receptors for the treatment of neuropsychiatric disorders.

Food-safety startups join battle against foodborne diseases

Artis Ventures seeks a $200 mln third fund

Betaworks targets $75 mln for sophomore fund

Betaworks Ventures is seeking to raise $75 million for its second fund, according to an SEC filing. Based in New York City and San Francisco, Betaworks is a product-focused, seed-stage venture firm.

Digital prescribing platform Xealth inks $11 mln Series A

Xealth, a digital prescribing platform, has raised $11 million in Series A financing. The investors were McKesson Ventures, Novartis, Philips, ResMed,Threshold Ventures, Providence Ventures, UPMC, Froedtert and the Medical College of Wisconsin Health Network.